Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Agreed, and the next financials and share structure update will be telling. The recent financials show no revenue and a lot of debt. Don't they already have projects up and running. Why no revenue? Let's move beyond the speculation
There is no proof of that either. We need numbers and not speculation
It's not that I don't believe Frank but the trading seems to show otherwise. We need updated SS and float numbers.
What's with all of the 10k trades? Anytime I've seen this on other OTC stocks, it's conversions.
September has been awhile. We need updates to know where things stand for sure
None of these are OTC. Prove to me that CLNV is being shorted. I'll keep my eye out on the share structure. It hasn't been updated since 11/01
It may not be, but it might be old convertible holders or retail.
I've been in the OTC many years. Naked shorting has never been proven in OTC. It's not worth it. It's just an excuse when the stock goes down. 100 percent of the time it's dilution, conversions, and retail.
I like this stock. But, naked shorting doesn't happen in the OTC. It just doesn't. It's either dilution or retail selling. That's it.
It's going much higher. I think a lot of profits from COSM will come over to CLNV. That's Frank's other stock and appears to be set to get numerous multimillion dollar deals.
Not according to who? ASU? You spoke with them? Proof or didn't happen.
BS. ASU would have already ordered a cease and desist if that were the case. ASU is fully aware and fully on board
QBIO expects the value of its investment to increase, due to quantifiable near-term and medium-term catalysts, including the signing of commercialization agreements by MRI, and completion of clinical milestones as part of its drug development program. In addition, utilizing MRI's internal pro-forma revenue projections for 2023 & 2024 and comparable market transactions, MRI's drug development pipeline and companion diagnostics, are estimated to achieve a net present value close to the billion-dollar mark as it moves from its near-term clinical milestones to commercial revenues.
Bye bye then.
If traders catch wind of this it could be the next COSM or KAL
Nobody is forcing you to be here.
There was no reason to discuss this a year away. Share price would have been higher at this point if they hadn't done this. It's almost like they don't expect a JV, gov funds, etc.
Move on then.
A cool website isn't going to make up for the huge dilution and R/S they are planning. This company fcked up. It had great potential once
Chart still looks prime for an upward move. Just need the right news for a pop
There is no sign the company is pumping. Quite the opposite in fact. They do very little updates/news/pumping. Share structure is very low. Doesn't have any elements of a P&D
There are no signs of dumping. The SS hasn't changed. Low volume too
This will close green
The latest update states that they are withdrawing the S1 speaks volumes. They are telling shareholders that they are expecting big revenue soon and S1 not needed. Not sure why this isn't being noticed
But this isn't a shell.
That's awesome!
It appears this stock has hit rock bottom. Time for a bounce?
OTC markets shows O/S at 447,968,934. Almost maxed out the A/S
Read the filing from yesterday.
This has been an infuriating experience
When this proposal goes up for a vote - whatever Adam votes is what will happen. Shareholders have zero say.
In hindsight, giving one person 60 percent voting power was a bad move. It's pointless to bring a vote for anything to shareholders. Whatever Adam wants, Adam gets. He's going to do whatever is in his best interest.
Adam has 60% voting power.
On August 23, 2022, the Board of Directors (the “Board”) of the Company authorized the issuance of fifty thousand (50,000) shares of the Series A Super Voting Preferred Convertible Stock (the “Series A Preferred”) pursuant to a Stock Purchase Agreement by and between the Company and Adam Lipson, a member of the Board of the Company, for the purchase price of Fifty Thousand Dollars ($50,000.00).
The Series A Preferred may vote on any action upon which holders of the Common Stock may vote, and they shall vote together as one class with voting rights equal to sixty percent (60%) of all of the issued and outstanding shares of Common Stock of the Company. The Series A Preferred shall automatically convert into shares of Common Stock upon the earlier of either a) the effectiveness of a Registration Statement under the Securities Act of 1933, or b) Twelve (12) months from the issuance of the Series A Preferred Stock at a ratio equal to the purchase prices per share of the Series A Preferred divided by $0.005. For more information regarding the Series A Preferred, please see Exhibit 3.1
Adam came on and purchased complete control of the company. Look at the prior filings. It seems he can do whatever he wants. It was dumb to allow him to have this much control.
I think IR doesn't care
If they got grant money then there was no need for this.
Agreed. Hey, we are probably going to do 1 - 1000 R/S a year from now. Stupid. Release the report, line up some JVs, get funding, and then announce the R/S a year from now when everything is solid.
I'll admit, they played their cards terribly. This could have been handled way better.